No Priors AI Meta to Layoff 20%, AI Cured Dogs Cancer, Nvidia's New Chip
Mar 16, 2026
A DIY mRNA vaccine designed with AI reportedly shrank a dog’s tumor. A major chipmaker teases next-generation AI silicon that could reshape inference speeds. Talks of a $10B enterprise rollout promise faster corporate AI adoption. Large-scale workforce cuts are being considered to free capital for massive AI investment.
AI Snips
Chapters
Transcript
Episode notes
Dog Saved By AI-Designed Personalized Cancer Vaccine
- Paul Conahan used ChatGPT and AlphaFold to analyze his rescue dog Rosie's tumor and design a personalized mRNA vaccine.
- After regulatory delay, Rosie received the vaccine in December and by March her tumor shrank ~75% to about a tennis-ball size.
Dog Case Foreshadows Human Personalized Medicine
- Personalized AI-driven medicine tested in dogs previews human applications being pursued by Moderna, Merck, and BioNTech.
- Jaeden argues regulation slows deployment: Rosie's treatment waited three months for safety approval despite limited prognosis.
Next NVIDIA Chips Will Reset Inference Performance
- NVIDIA's GTC reveal will likely set a new performance ceiling for inference and large-scale AI deployment.
- Jaeden highlights rising demand for inference compute as companies shift from training to massive deployment.